Amicus Therapeutics, Inc.
Overview
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering innovative medicines for the rare disease community. The company's primary platform involves the development of advanced therapies to address a wide range of rare conditions, with a strong emphasis on lysosomal storage disorders.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Amicus Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Amicus Therapeutics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.